Kidney disease is a growing global concern, affecting approximately 850 million people worldwide. In China, chronic kidney disease has reached a prevalence rate of 8.2%, impacting one in every ten people. This makes kidney health a critical issue, underscoring the importance of reliable diagnostic methods. Creatinine levels, a byproduct of muscle metabolism, are one of the most essential biomarkers for assessing kidney function. Elevated creatinine levels often signal impaired kidney function, making accurate and efficient testing methods vital for early detection and management.

The Need for Improved Creatinine Testing Methods

Traditionally, clinical creatinine testing relied on the Jaffe reaction, also known as the alkaline picrate method. While this method has been widely used, it is prone to interference from other substances, leading to inaccurate results. In contrast, enzymatic creatinine testing, which involves methods such as creatinine amidohydrolase and creatinine oxidase, offers superior specificity, accuracy, and resistance to interference. Among these, the creatinine oxidase method stands out, providing a broader linear range and enhanced reliability, particularly in clinical settings where sample quality can vary.

However, despite the advances in enzymatic methods, challenges such as reagent stability, interference from substances like calcium dobesilate, and the complexity of multi-enzyme systems remain. This is where HZYMES steps in with a groundbreaking approach to creatinine testing.

HZYMES’ Innovations in Creatinine Testing

HZYMES has taken the enzymatic testing method a step further, introducing key innovations that significantly enhance the performance of creatinine test kits. The company has focused on improving the stability and accuracy of the core enzymes involved in the testing process. Two key enzymes—creatinase and catalase—play pivotal roles in ensuring reliable and consistent results.

Creatinase and Catalase Upgrades

Creatinase, a crucial enzyme in the creatinine detection system, is responsible for hydrolyzing creatinine into intermediate compounds for further analysis. HZYMES has optimized this enzyme through enzyme-directed evolution, resulting in the 13M4 creatinase mutant, which demonstrates enhanced thermal stability and enzyme activity. This innovation has led to a substantial increase in the enzyme’s half-life and performance, ensuring stable reagent functionality even under challenging conditions.

Catalase, another important enzyme, is added to eliminate interference from endogenous creatine, which can skew test results. HZYMES has made significant strides in optimizing catalase’s structure and purification process, achieving a remarkable 20-fold increase in its half-life at elevated temperatures. This upgrade ensures that the reagents maintain their performance over extended periods, even after prolonged exposure to high temperatures.

Enhanced Stability and Reliability

With these enzymatic upgrades, HZYMES has significantly improved the stability and reliability of its creatinine test kits. The optimized enzymes are capable of maintaining their activity over extended periods, even under thermal stress, ensuring accurate clinical readings. In comparative clinical testing, the HZYMES creatinine test kit demonstrated a deviation of less than 5% when compared to imported brands, with a correlation coefficient greater than 0.999. This high level of precision highlights the kit’s ability to deliver consistent and accurate results, making it a trustworthy tool for kidney health diagnostics.

Broad Linear Range and Anti-Interference Technology

HZYMES’ creatinine test kits offer an impressive linear range of 10 to 8840 μmol/L, making them suitable for testing both blood and urine samples. This broad range reduces the need for sample dilution, enhancing testing efficiency and accuracy. Additionally, HZYMES has integrated advanced anti-interference technology to eliminate the effects of substances that can affect creatinine measurements.

For instance, HZYMES’ kits are resistant to interference from substances such as calcium dobesilate, acetaminophen, ascorbic acid, bilirubin, hemoglobin, and lipemia. This is especially important for patients with renal dysfunction, who often present with elevated levels of these substances. The inclusion of anti-CaD technology further ensures that the test kits can accurately measure creatinine levels without being affected by calcium dobesilate, a known interferent.

A Comprehensive Solution for Kidney Health Diagnostics

HZYMES’ commitment to excellence extends beyond product development. The company specializes in providing comprehensive creatinine reagent solutions, from core enzyme selection to customized reagent development and OEM collaboration. By offering tailored solutions, HZYMES is able to meet the specific needs of its clients, helping them deliver high-quality, cost-effective diagnostic tools to healthcare providers around the world.

Conclusion

As kidney disease continues to pose a significant health threat globally, the need for accurate and reliable creatinine testing becomes more urgent. HZYMES’ innovative approach to creatinine testing, through its enhanced enzymatic methods, upgraded reagents, and anti-interference technologies, represents a significant leap forward in kidney health diagnostics. With proven accuracy, stability, and a broad testing range, HZYMES’ creatinine test kits provide a crucial tool for early detection and monitoring of kidney disease, improving patient outcomes and supporting healthcare professionals in their fight against kidney-related health issues.

For more information and to explore customized reagent solutions, contact HZYMES and start your journey towards better kidney health diagnostics.